Correlation Between Citigroup and GeneReach Biotechnology
Can any of the company-specific risk be diversified away by investing in both Citigroup and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and GeneReach Biotechnology, you can compare the effects of market volatilities on Citigroup and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and GeneReach Biotechnology.
Diversification Opportunities for Citigroup and GeneReach Biotechnology
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Citigroup and GeneReach is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Citigroup i.e., Citigroup and GeneReach Biotechnology go up and down completely randomly.
Pair Corralation between Citigroup and GeneReach Biotechnology
Taking into account the 90-day investment horizon Citigroup is expected to generate 2.15 times more return on investment than GeneReach Biotechnology. However, Citigroup is 2.15 times more volatile than GeneReach Biotechnology. It trades about 0.2 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.1 per unit of risk. If you would invest 6,412 in Citigroup on August 30, 2024 and sell it today you would earn a total of 604.00 from holding Citigroup or generate 9.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Citigroup vs. GeneReach Biotechnology
Performance |
| Timeline |
| Citigroup |
| GeneReach Biotechnology |
Citigroup and GeneReach Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Citigroup and GeneReach Biotechnology
The main advantage of trading using opposite Citigroup and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.| Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
| GeneReach Biotechnology vs. Medigen Vaccine Biologics | GeneReach Biotechnology vs. OBI Pharma | GeneReach Biotechnology vs. TaiMed Biologics | GeneReach Biotechnology vs. Adimmune Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |